Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Fortrea Holdings Inc's Business Segments
Fortrea Holdings Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of Q2 FY2026
Reportable Segments
1
Largest Segment
Clinical Services
Total Revenue
$ 678
Regions Reported
2
Revenue Share by Reportable Segment - Q2 FY2026
- Clinical Services100%
Revenue by Reportable Segment - Q2 FY2026
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Clinical Services | $ 678 | 100% |
Revenue Share by Region - Q2 FY2026
- North America47.1%
- Europe32.4%
Revenue by Geographic Region - Q2 FY2026
| Region | Revenue (Millions) | % of Total |
|---|---|---|
| North America | $ 320 | 47.1% |
| Europe | $ 220 | 32.4% |
Description of Fortrea Holdings Inc
Fortrea Holdings Inc. is a global investment holding company with diverse interests in various industries. The company's mission is to create long-term value for its shareholders through strategic investments, operational excellence, and responsible business practices.
The headquarters of Fortrea Holdings Inc. are located in a prominent business district, with subsidiary offices and operations spread across several countries. The company has a strong management team with expertise in finance, investment, and business development. They focus on identifying and acquiring businesses with potential for growth, and actively participate in their strategic planning and management.
One of the main sectors in which Fortrea Holdings Inc. has investments is technology and innovation. The company identifies promising tech startups and provides them with the necessary capital, resources, and guidance to help them grow rapidly. Through its investments in the technology sector, Fortrea Holdings Inc. aims to contribute to advancements in fields such as artificial intelligence, blockchain, cybersecurity, and cloud computing.
Fortrea Holdings Inc. also has significant investments in the renewable energy sector. The company recognizes the critical need for sustainable and clean energy solutions and actively supports companies that develop and implement such technologies. Their investments in renewable energy projects include solar, wind, hydroelectric, and geothermal power generation.
Another focus area for Fortrea Holdings Inc. is the healthcare industry. The company identifies and invests in healthcare startups that are working on groundbreaking medical technologies, pharmaceutical research, and healthcare delivery systems. By supporting these companies, Fortrea Holdings Inc. aims to revolutionize the healthcare sector, improve patient outcomes, and make healthcare more accessible and affordable.
In addition to technology, renewable energy, and healthcare, Fortrea Holdings Inc. has diversified investments in other sectors such as real estate, manufacturing, hospitality, and consumer goods. They actively seek opportunities in emerging markets and actively contribute to the economic development of these regions through their investments.
Fortrea Holdings Inc. is committed to responsible business practices and sustainability. They prioritize environmental, social, and governance (ESG) factors in their investment decisions and work closely with their portfolio companies to ensure compliance with international standards and regulations. The company also actively supports philanthropic initiatives and community development programs in the areas where they operate.
Overall, Fortrea Holdings Inc. is a global investment holding company with a diverse portfolio of investments in various industries. They focus on identifying and supporting promising startups and companies to create long-term value for their shareholders, while also making a positive impact on society and the environment.
The headquarters of Fortrea Holdings Inc. are located in a prominent business district, with subsidiary offices and operations spread across several countries. The company has a strong management team with expertise in finance, investment, and business development. They focus on identifying and acquiring businesses with potential for growth, and actively participate in their strategic planning and management.
One of the main sectors in which Fortrea Holdings Inc. has investments is technology and innovation. The company identifies promising tech startups and provides them with the necessary capital, resources, and guidance to help them grow rapidly. Through its investments in the technology sector, Fortrea Holdings Inc. aims to contribute to advancements in fields such as artificial intelligence, blockchain, cybersecurity, and cloud computing.
Fortrea Holdings Inc. also has significant investments in the renewable energy sector. The company recognizes the critical need for sustainable and clean energy solutions and actively supports companies that develop and implement such technologies. Their investments in renewable energy projects include solar, wind, hydroelectric, and geothermal power generation.
Another focus area for Fortrea Holdings Inc. is the healthcare industry. The company identifies and invests in healthcare startups that are working on groundbreaking medical technologies, pharmaceutical research, and healthcare delivery systems. By supporting these companies, Fortrea Holdings Inc. aims to revolutionize the healthcare sector, improve patient outcomes, and make healthcare more accessible and affordable.
In addition to technology, renewable energy, and healthcare, Fortrea Holdings Inc. has diversified investments in other sectors such as real estate, manufacturing, hospitality, and consumer goods. They actively seek opportunities in emerging markets and actively contribute to the economic development of these regions through their investments.
Fortrea Holdings Inc. is committed to responsible business practices and sustainability. They prioritize environmental, social, and governance (ESG) factors in their investment decisions and work closely with their portfolio companies to ensure compliance with international standards and regulations. The company also actively supports philanthropic initiatives and community development programs in the areas where they operate.
Overall, Fortrea Holdings Inc. is a global investment holding company with a diverse portfolio of investments in various industries. They focus on identifying and supporting promising startups and companies to create long-term value for their shareholders, while also making a positive impact on society and the environment.
Fortrea Holdings Inc. is known for its focus on providing innovative solutions in the healthcare and pharmaceutical sectors. The company specializes in various segments, products, and services aimed at improving patient outcomes and enhancing clinical development processes. Below is an extensive description of the segments, products, and services that Fortrea Holdings Inc. offers.
1. Clinical Development Services
a. Clinical Trials Management
Fortrea Holdings Inc. offers comprehensive management services for clinical trials across multiple phases. This includes site selection, patient recruitment strategies, trial monitoring, and data management. The company aims to streamline the clinical trial process to reduce time and costs while ensuring regulatory compliance.
b. Regulatory Affairs Consulting
The company provides consulting services that help clients navigate the complex landscape of regulatory requirements. This includes assistance with submissions to regulatory bodies, support for compliance with local and international regulations, and guidance on best practices for maintaining regulatory standards throughout the product lifecycle.
c. Biometrics and Data Analytics
Fortrea Holdings Inc. utilizes advanced statistical analysis and data management services to support clinical development. This encompasses services like biostatistics, data management, and analytics that provide insights into trial results, aiding decision-making and optimizing study designs.
Pharmaceutical Development Services
a. Formulation Development
Fortrea focuses on the early stages of drug development, offering formulation development services to optimize the delivery of active pharmaceutical ingredients (APIs). This includes developing solid, liquid, and semi-solid formulations tailored to meet specific therapeutic needs.
b. Technology Transfer
The company facilitates technology transfer processes between development and commercial manufacturing, ensuring that scale-up processes are efficient and that product integrity is maintained. This includes transferring knowledge and processes for manufacturing, analytical methods, and quality assurance systems.
c. Analytical Services
Fortrea Holdings provides comprehensive analytical testing services to ensure the quality and consistency of pharmaceutical products. These services encompass stability testing, method validation, and impurity profiling, essential for meeting regulatory standards.
Commercialization Services
a. Market Access Strategy
Fortrea Holdings helps clients devise effective market access strategies to ensure new therapies reach intended markets. This includes pricing strategy development, reimbursement pathway analysis, and the creation of value propositions to engage payers and providers.
b. Sales and Marketing Support
The company offers sales and marketing services designed to enhance product positioning and market presence. This includes multi-channel marketing solutions, sales force training, and promotional campaign development tailored to specific therapeutic areas.
c. Supply Chain Management
Fortrea Holdings assists clients in establishing and optimizing their supply chain operations. This involves logistics support, inventory management, and distribution strategies to ensure timely delivery of products while maintaining cost efficiency.
Patient-Centric Services
a. Patient Recruitment and Retention
Recognizing the critical role of patient involvement in clinical trials, Fortrea focuses on innovative patient recruitment and retention strategies. This involves utilizing patient engagement platforms and community outreach initiatives to enhance participation and minimize dropouts in clinical studies.
b. Real-World Evidence Solutions
To support product development and commercialization, Fortrea offers services to collect and analyze real-world evidence (RWE). This data helps in understanding the effects of medical interventions in broader, more diverse patient populations outside of controlled clinical trial settings.
c. Patient Support Programs
Fortrea Holdings is committed to improving patient experience and adherence through tailored support programs. These programs may include educational resources, counseling services, and financial assistance to support patients throughout their treatment journey.
Therapeutic Area Expertise
Fortrea Holdings Inc. has developed capabilities across several therapeutic areas which include but are not limited to:
- Oncology: Focused on the development of novel cancer therapies and supportive care strategies.
- Neurology: Products and services designed for neurological disorders, enhancing patient outcomes and treatment efficacy.
- Cardiovascular: Development of pharmaceutical solutions that address cardiovascular diseases.
- Infectious Diseases: Solutions aimed at combating infectious diseases, with a focus on rapid response and effective treatment strategies.
- Rare Diseases: Services and products aimed at addressing the unique challenges associated with rare diseases, including orphan drug development.
Conclusion
Fortrea Holdings Inc. is positioned as a versatile player in the fields of clinical and pharmaceutical development, offering a wide range of services designed to support healthcare companies at various stages of the drug development lifecycle. The company’s commitment to innovation and patient-centric solutions underscores its role in enhancing healthcare delivery and improving patient outcomes across diverse therapeutic areas.
1. Clinical Development Services
a. Clinical Trials Management
Fortrea Holdings Inc. offers comprehensive management services for clinical trials across multiple phases. This includes site selection, patient recruitment strategies, trial monitoring, and data management. The company aims to streamline the clinical trial process to reduce time and costs while ensuring regulatory compliance.
b. Regulatory Affairs Consulting
The company provides consulting services that help clients navigate the complex landscape of regulatory requirements. This includes assistance with submissions to regulatory bodies, support for compliance with local and international regulations, and guidance on best practices for maintaining regulatory standards throughout the product lifecycle.
c. Biometrics and Data Analytics
Fortrea Holdings Inc. utilizes advanced statistical analysis and data management services to support clinical development. This encompasses services like biostatistics, data management, and analytics that provide insights into trial results, aiding decision-making and optimizing study designs.
Pharmaceutical Development Services
a. Formulation Development
Fortrea focuses on the early stages of drug development, offering formulation development services to optimize the delivery of active pharmaceutical ingredients (APIs). This includes developing solid, liquid, and semi-solid formulations tailored to meet specific therapeutic needs.
b. Technology Transfer
The company facilitates technology transfer processes between development and commercial manufacturing, ensuring that scale-up processes are efficient and that product integrity is maintained. This includes transferring knowledge and processes for manufacturing, analytical methods, and quality assurance systems.
c. Analytical Services
Fortrea Holdings provides comprehensive analytical testing services to ensure the quality and consistency of pharmaceutical products. These services encompass stability testing, method validation, and impurity profiling, essential for meeting regulatory standards.
Commercialization Services
a. Market Access Strategy
Fortrea Holdings helps clients devise effective market access strategies to ensure new therapies reach intended markets. This includes pricing strategy development, reimbursement pathway analysis, and the creation of value propositions to engage payers and providers.
b. Sales and Marketing Support
The company offers sales and marketing services designed to enhance product positioning and market presence. This includes multi-channel marketing solutions, sales force training, and promotional campaign development tailored to specific therapeutic areas.
c. Supply Chain Management
Fortrea Holdings assists clients in establishing and optimizing their supply chain operations. This involves logistics support, inventory management, and distribution strategies to ensure timely delivery of products while maintaining cost efficiency.
Patient-Centric Services
a. Patient Recruitment and Retention
Recognizing the critical role of patient involvement in clinical trials, Fortrea focuses on innovative patient recruitment and retention strategies. This involves utilizing patient engagement platforms and community outreach initiatives to enhance participation and minimize dropouts in clinical studies.
b. Real-World Evidence Solutions
To support product development and commercialization, Fortrea offers services to collect and analyze real-world evidence (RWE). This data helps in understanding the effects of medical interventions in broader, more diverse patient populations outside of controlled clinical trial settings.
c. Patient Support Programs
Fortrea Holdings is committed to improving patient experience and adherence through tailored support programs. These programs may include educational resources, counseling services, and financial assistance to support patients throughout their treatment journey.
Therapeutic Area Expertise
Fortrea Holdings Inc. has developed capabilities across several therapeutic areas which include but are not limited to:
- Oncology: Focused on the development of novel cancer therapies and supportive care strategies.
- Neurology: Products and services designed for neurological disorders, enhancing patient outcomes and treatment efficacy.
- Cardiovascular: Development of pharmaceutical solutions that address cardiovascular diseases.
- Infectious Diseases: Solutions aimed at combating infectious diseases, with a focus on rapid response and effective treatment strategies.
- Rare Diseases: Services and products aimed at addressing the unique challenges associated with rare diseases, including orphan drug development.
Conclusion
Fortrea Holdings Inc. is positioned as a versatile player in the fields of clinical and pharmaceutical development, offering a wide range of services designed to support healthcare companies at various stages of the drug development lifecycle. The company’s commitment to innovation and patient-centric solutions underscores its role in enhancing healthcare delivery and improving patient outcomes across diverse therapeutic areas.